Analytical Data
-
Gene name
FimF41a
- Application
-
Alternative Names
Adhesin F41
-
Species
Escherichia coli
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P11900
-
Expression Region
23-277aa
-
Molecular Weight
34.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FimF41a is a recombinant protein that has garnered interest due to its potential applications in biotechnology and medicine. It is derived from a fimbrial adhesin of certain pathogenic bacteria, which play key roles in microbial adhesion and biofilm formation, crucial factors in the development of infections. Understanding the structure and function of FimF41a can provide insights into bacterial behavior and host interactions, making it a target for vaccine development and therapeutic interventions. The study of this protein is pivotal for advancing strategies to combat bacterial infections, particularly those caused by multidrug-resistant strains. Additionally, FimF41a may serve as a model for developing novel biomaterials and biosensors, utilizing its adhesive properties in various applications. Research efforts focus on its expression, purification, and functional characterization to elucidate its mechanisms of action. This knowledge could lead to innovative solutions for preventing and treating infections, addressing a significant public health challenge. Overall, the investigation of FimF41a as a recombinant protein exemplifies the intersection of microbiology, immunology, and materials science, emphasizing the need for multidisciplinary approaches in tackling infectious diseases.
